The global digital pathology market is projected to be valued at USD 383.9 Million in 2016 and is expected to grow at a CAGR of 12.3% from 2017 to reach to USD 756.1 Million by 2022.

Growth in the market is mainly driven by factors such as the growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and increasing initiatives by governments and industry players. Base year considered for the report is 2016 and the forecast period is 2017–2022.

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=844

Drivers
1 Increasing Adoption of Digital Pathology to Enhance Lab Efficiency
2 Rising Prevalence of Cancer
3 Growing Applications of Digital Pathology in Drug Development and Companion Diagnostics
4 Ease of Consultation Enabled By Digital Pathology
5 Increasing Initiatives By Governments and Industry Players

Restraints
1 High Cost of Digital Pathology Systems

Opportunities
1 Overcoming the Shortage of Pathologists Through Digital Pathology
2 Introduction of Affordable Scanners for Private Pathology Practices
3 Personalized Medicine
4 Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems

The prominent players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), and Philips (Netherlands).

Know More: https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html